During the past decade, Biotrial Rennes conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Biotrial Rennes" are "Healthy" (3 trials), "Insomnia" (1 trials) and "Parkinson Disease" (1 trials). Many other conditions were trialed in "Biotrial Rennes" in a lesser frequency.

Most popular intervention types in "Biotrial Rennes" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Denosumab" (1 trials), "Dreem 3 System vs PSG" (1 trials), "Foliglurax 10 mg (treatment A)" (1 trials), "Foliglurax 30 mg (treatment B)" (1 trials) and "Placebo (treatment C)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Biotrial Rennes" are 3 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Biotrial Rennes". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Biotrial Rennes, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Biotrial Rennes, 3 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".